Schedule 2 to the Principal Order is amended by inserting after subparagraph (iv) in paragraph (c) of item 2092 the following item: 2092M. Penciclovir in preparations for dermal use containing 1% or less of penciclovir.
2092M. Penciclovir in preparations for dermal use containing 1% or less of penciclovir.
2092M.
Penciclovir in preparations for dermal use containing 1% or less of penciclovir.